Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries

Regulators and pharmaceutical companies across the world are intensifying efforts to get increasingly complex and innovative drugs to patients with high unmet medical need in the shortest possible time frame. This article reviews pathways to expedite drug development and approval available in member...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Pedro, Jain, Ritesh, Rosenkrands-Lange, Elizabeth, Hey, Claudia, Koban, Marén U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734413/
https://www.ncbi.nlm.nih.gov/pubmed/36463352
http://dx.doi.org/10.1007/s43441-022-00480-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734413/
https://www.ncbi.nlm.nih.gov/pubmed/36463352
http://dx.doi.org/10.1007/s43441-022-00480-3

Ejemplares similares